TY  - THES
AU  - von Soosten, Laura
TI  - Establishing experimental therapeutic modalities and CRISPR/Cas9 screening platforms to interrogate vulnerabilities in pediatric high-grade glioma (pHGG)
PB  - Ruprecht-Karls-University Heidelberg
VL  - Dissertation
M1  - DKFZ-2025-02689
PY  - 2025
N1  - Dissertation, Ruprecht-Karls-University Heidelberg, 2025
LB  - PUB:(DE-HGF)11
UR  - https://inrepo02.dkfz.de/record/306699
ER  -